M. SÜNBÜL And M. Agirbasli, "Psoriasis and Atherosclerosis: Is There a Need For Novel Biomarkers Assessing Cardiovascular Risk?," CURRENT PHARMACEUTICAL DESIGN , vol.20, no.4, pp.529-535, 2014
SÜNBÜL, M. And Agirbasli, M. 2014. Psoriasis and Atherosclerosis: Is There a Need For Novel Biomarkers Assessing Cardiovascular Risk?. CURRENT PHARMACEUTICAL DESIGN , vol.20, no.4 , 529-535.
SÜNBÜL, M., & Agirbasli, M., (2014). Psoriasis and Atherosclerosis: Is There a Need For Novel Biomarkers Assessing Cardiovascular Risk?. CURRENT PHARMACEUTICAL DESIGN , vol.20, no.4, 529-535.
SÜNBÜL, MURAT, And Mehmet Agirbasli. "Psoriasis and Atherosclerosis: Is There a Need For Novel Biomarkers Assessing Cardiovascular Risk?," CURRENT PHARMACEUTICAL DESIGN , vol.20, no.4, 529-535, 2014
SÜNBÜL, MURAT And Agirbasli, Mehmet. "Psoriasis and Atherosclerosis: Is There a Need For Novel Biomarkers Assessing Cardiovascular Risk?." CURRENT PHARMACEUTICAL DESIGN , vol.20, no.4, pp.529-535, 2014
SÜNBÜL, M. And Agirbasli, M. (2014) . "Psoriasis and Atherosclerosis: Is There a Need For Novel Biomarkers Assessing Cardiovascular Risk?." CURRENT PHARMACEUTICAL DESIGN , vol.20, no.4, pp.529-535.
@article{article, author={MURAT SÜNBÜL And author={Mehmet Agirbasli}, title={Psoriasis and Atherosclerosis: Is There a Need For Novel Biomarkers Assessing Cardiovascular Risk?}, journal={CURRENT PHARMACEUTICAL DESIGN}, year=2014, pages={529-535} }